Tech Company Financing Transactions
Decision Biomarkers Funding Round
On 12/31/2007, Decision Biomarkers raised $9.5 million in financing from Oxford Bioscience Partners and private investors.
Transaction Overview
Company Name
Announced On
12/31/2007
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Undisclosed
Investors
Oxford Bioscience Partners (Michael Lytton)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
150 Bear Hill Road
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Decision Biomarkers is a company that has developed an automated multiplex immunoassay platform and a biomarker panel assays for its lead product.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jean Montagu
Chief Executive Officer
Roger Dowd
Chief Financial Officer
Charles Popkin
VP - Bus. Development
Joe Blanchard
VP - Engineering
Walter Leslie
VP - Marketing
Glenn Barney
VP - R & D
Peter Maimonis
Browse more venture capital transactions:
Prev: 12/31/2007: Egenera venture capital transaction
Next: 12/31/2007: Antipodean Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs